Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug–Microbiota Interaction in Colon Cancer Therapy: Impact of Antibiotics
Ali A. Mohamed, Harry Menon, Marina Chulkina, et al.
Biomedicines (2021) Vol. 9, Iss. 3, pp. 259-259
Open Access | Times Cited: 21

Showing 21 citing articles:

Self‐Thermophoretic Nanoparticles Enhance Intestinal Mucus Penetration and Reduce Pathogenic Bacteria Interception in Colorectal Cancer
Zhi‐Hao Wang, Wanting Huang, Shuhao Zhang, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 17
Closed Access | Times Cited: 30
Thermal Inkjet Printing: Prospects and Applications in the Development of Medicine
Jasim Uddin, Jasmin Hassan, Dennis Douroumis
Technologies (2022) Vol. 10, Iss. 5, pp. 108-108
Open Access | Times Cited: 30
Unraveling the role of medicinal plants and Gut microbiota in colon cancer: Towards microbiota- based strategies for prevention and treatment
Arumugam Vignesh, Thomas Cheeran Amal, S. Selvakumar, et al.
Health Sciences Review (2023) Vol. 9, pp. 100115-100115
Open Access | Times Cited: 14
Exploring the Inflammatory Pathogenesis of Colorectal Cancer
Ahamed Khalyfa, Shil Punatar, Rida Aslam, et al.
Diseases (2021) Vol. 9, Iss. 4, pp. 79-79
Open Access | Times Cited: 27
Ceftazidime and Usnic Acid Encapsulated in Chitosan-Coated Liposomes for Oral Administration against Colorectal Cancer-Inducing Escherichia coli
Jaqueline Barbosa de Souza, Davi de Lacerda Coriolano, Rayza Camila dos Santos Silva, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 802-802
Open Access | Times Cited: 2
The microbiome of diverticulitis
Nimalan A. Jeganathan, Emily Davenport, Gregory S. Yochum, et al.
Current Opinion in Physiology (2021) Vol. 22, pp. 100452-100452
Closed Access | Times Cited: 14
Impact of Colorectal Cancer Sidedness and Location on Therapy and Clinical Outcomes: Role of Blood-Based Biopsy for Personalized Treatment
Sasha Waldstein, Marianne Spengler, Iryna V. Pinchuk, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 7, pp. 1114-1114
Open Access | Times Cited: 5
A Novel Pyroptosis-Associated Long Noncoding RNA Signature to Predict the Prognosis of Patients with Colorectal Cancer
Sijun Chen, Jianwei Zhu, Xiaofei Zhi
International Journal of General Medicine (2021) Vol. Volume 14, pp. 6111-6123
Open Access | Times Cited: 11
8-Methoxyflindersine-Induced Apoptosis and Cell Cycle Disorder Involving MAPK Signaling Activation in Human Colorectal Cancer Cells
Dianbao Zhang, Yunmei Fu, Ying Liu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8039-8039
Open Access | Times Cited: 2
Alkaline media‐sensitive nanocarrier based on carboxylated cyclodextrin for targeted delivery of anti‐colon drug
Shuai Chen, Fang‐Dao Zhu, Bilian Li, et al.
Journal of Applied Polymer Science (2022) Vol. 139, Iss. 46
Closed Access | Times Cited: 4
Forecasting Survival Rates in Metastatic Colorectal Cancer Patients Undergoing Bevacizumab-Based Chemotherapy: A Machine Learning Approach
Sergio Sánchez-Herrero, Abtin Tondar, Elena Pérez Bernabeu, et al.
BioMedInformatics (2024) Vol. 4, Iss. 1, pp. 733-753
Open Access
The Potential of Integrative Cancer Treatment Using Melatonin and the Challenge of Heterogeneity in Population-Based Studies: A Case Report of Colon Cancer and a Literature Review
Smorodin Ep, Valentin Chuzmarov, Toomas Veidebaum
Current Oncology (2024) Vol. 31, Iss. 4, pp. 1994-2023
Open Access
Contribution of PKS+ Escherichia coli to Colon Carcinogenesis through the inhibition of exosomal miR-885-5p
Xiaoming He, Enbo Ren, Lujia Dong, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37346-e37346
Open Access
Lifestyle, dietary pattern and colorectal cancer: a case-control study
Zahra Rostampoor, Sima Afrashteh, Μohammad Mohammadianpanah, et al.
BMC Nutrition (2024) Vol. 10, Iss. 1
Open Access
THE PROTECTIVE ROLE OF INTESTINAL MICROBIOTA IN COLORECTAL CANCER TREATMENT: A SCOPING REVIEW
Jéssica Rosa Thiesen Cunha, Elissandra Maria Faiz, E.M. Bueno, et al.
Texto & Contexto - Enfermagem (2024) Vol. 33
Open Access
O PAPEL PROTETIVO DA MICROBIOTA INTESTINAL NO TRATAMENTO DO CÂNCER COLORRETAL: REVISÃO DE ESCOPO
Jéssica Rosa Thiesen Cunha, Elissandra Maria Faiz, E.M. Bueno, et al.
Texto & Contexto - Enfermagem (2024) Vol. 33
Open Access
Antibiotic use during radical surgery in stage I-III colorectal cancer: correlation with outcomes?
Mingyue Xu, Yuanyuan Chen, Panhua Li, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
The Colloquy between Microbiota and the Immune System in Colon Cancer: Repercussions on the Cancer Therapy
Reena V. Saini, Soumya Pal, Adesh K. Saini, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 43, pp. 3478-3485
Closed Access | Times Cited: 2
Special Issue: The Role of Gut Microbiota in Gastrointestinal Cancers—From Pathogenesis to Therapeutic Perspectives
Ryota Niikura
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2950-2950
Open Access
Rewiring of Drug Metabolism and Its Cross‐talk with Metabolic Reprogramming in Cancer
Subhabrata Majumder, Soumen K. Manna
(2022), pp. 923-966
Closed Access
Emerging therapeutics
Gennaro Ciliberto
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access
Page 1

Scroll to top